Cite this article
13
Downloads
1
Citations
37
Views
Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Case Report
Comparison of efficacy of different embolic agents on uterine leiomyoma
Show Less
1
Medical College, Xi'an Jiaotong University, Xi'an
2
Department of Interventional Radiology, The First Affiliated Hospital of Baotou Medical College, Baotou
3
Baotou Medical College, Baotou, Inner Mongolia (China)
Clin. Exp. Obstet. Gynecol. 2016, 43(1), 114–118;
https://doi.org/10.12891/ceog2015.2016
Published: 10 February 2016
Abstract
The aim of this study was to explore the efficacies, postoperative side effects, and complications of uterine artery embolization (UAE) treatments for uterine leiomyoma (UL) with different embolic agents. The study included 107 patients with UL that were treated with UAE with polyvinyl alcohol (PVA group) or pingyangmycin lipiodol emulsion and silk-segment (PLES group). Six months later, the improvement rate of anaemia, the menstrual improvement rate, the incidence rate of fever, the disappearance rates of compression symptoms and abdominal symptoms in the PVA group were 93.8%, 94.7%, 22.0%, 60.0%, and 88.9%, respectively, which showed no significant difference from those in the PLES group (90.5%, 92.3%, 84.8%, 53.3%, and 81.3%, respectively). The incidence rate of fever after embolization in PVA group was significantly lower than that in PLES group (c2=41.958, p = 0.000). However, the efficacy, improvement rate of symptoms, and postoperative side effects of two groups showed no significant difference (p > 0.05). PVA and PLES have significant efficacy for UAE treatment on patients with UL.
Keywords
Hysteromyoma
Embolization
Polyvinyl alcohol
Pingyangmycin lipiodol emulsion